FDA Makes Big Change Hours After Rejecting Booster Vax For All.…

Sept 17 (Reuters) — Advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and those at high risk of severe illness, after overwhelmingly rejecting a call for broader approval.

The panel also recommended that the FDA include healthcare workers and others at high risk of occupational exposure to the virus that causes COVID-19, such as teachers.

Despite the narrowed scope of the proposed authorization, the panel’s recommendation would cover most Americans who got their shots in the earliest stages of the U.S. vaccination campaign.

“Today was an important step forward in providing better protection to Americans from COVID-19,” White House spokesperson Kevin Munoz said. “We stand ready to provide booster shots to eligible Americans once the process concludes at the end of next week,” he said.

The FDA is expected to make its decision on the third round of shots soon. It is not bound by the panel’s recommendation but will take it into consideration.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Send this to a friend